S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

Hemispherx BioPharma SEC Filings & 10K Form (NYSEAMERICAN:HEB)

$1.96
0.00 (0.00 %)
(As of 09/6/2019)
Today's Range
$1.90
Now: $1.96
$2.06
50-Day Range N/A
52-Week Range
$1.69
Now: $1.96
$14.81
Volume111,364 shs
Average Volume102,599 shs
Market Capitalization$4.79 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

SEC Filings

Hemispherx BioPharma (NYSEAMERICAN:HEB) SEC Filings

DateFilerForm TypeView
10/17/2019
4:06 PM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
3:57 PM
Hemispherx BioPharma (Issuer)
APPELROUTH STEWART (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
3:42 PM
Hemispherx BioPharma (Issuer)
RODINO III PETER W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
3:32 PM
Hemispherx BioPharma (Issuer)
EQUELS THOMAS K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
5:30 AM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2019
5:40 AM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2019
11:43 AM
Hemispherx BioPharma (Issuer)
APPELROUTH STEWART (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2019
11:27 AM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
5:14 AM
Hemispherx BioPharma (Subject)
Anson Funds Management LP (Filed by)
Form SC 13G
09/27/2019
4:00 PM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2019
4:00 PM
Hemispherx BioPharma (Filer)
Form 424B4
09/25/2019
11:15 PM
Hemispherx BioPharma (Filer)
Form EFFECT
09/24/2019
7:32 PM
Hemispherx BioPharma (Filer)
Form S-1/A
09/24/2019
2:37 PM
Hemispherx BioPharma (Filer)
Form S-1/A
09/24/2019
5:45 AM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2019
10:37 AM
Hemispherx BioPharma (Issuer)
LINTAL ELLEN M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2019
1:00 PM
Hemispherx BioPharma (Issuer)
APPELROUTH STEWART (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
12:39 PM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
5:50 AM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2019
5:30 AM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2019
12:36 PM
Hemispherx BioPharma (Issuer)
APPELROUTH STEWART (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
12:22 PM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
4:04 PM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
7:00 AM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
3:30 PM
Hemispherx BioPharma (Filer)
Form DEF 14A
08/20/2019
10:20 AM
APPELROUTH STEWART (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
9:56 AM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
11:45 AM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
11:33 AM
APPELROUTH STEWART (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2019
1:09 PM
Hemispherx BioPharma (Filer)
Form 424B5
07/22/2019
12:46 PM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2019
11:58 AM
APPELROUTH STEWART (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2019
11:29 AM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2019
1:11 PM
APPELROUTH STEWART (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2019
12:50 PM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
3:05 PM
EQUELS THOMAS K. (Filed by)
Hemispherx BioPharma (Subject)
Form SC 13D
06/28/2019
9:51 AM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2019
2:32 PM
EQUELS THOMAS K. (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
11:17 AM
EQUELS THOMAS K. (Reporting)
Hemispherx BioPharma (Issuer)
Form 4/A
06/25/2019
10:40 AM
Hemispherx BioPharma (Issuer)
STRAYER DAVID R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
10:04 AM
Hemispherx BioPharma (Issuer)
RODINO III PETER W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
9:19 AM
APPELROUTH STEWART (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
4:01 PM
Hemispherx BioPharma (Issuer)
SPRINGATE WAYNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:14 PM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
10:11 AM
EQUELS THOMAS K. (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:04 PM
EQUELS THOMAS K. (Filed by)
Hemispherx BioPharma (Subject)
Form SC 13D/A
06/18/2019
12:20 PM
APPELROUTH STEWART (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
12:08 PM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
9:58 AM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
3:48 PM
APPELROUTH STEWART (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
3:11 PM
Hemispherx BioPharma (Issuer)
SPRINGATE WAYNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
2:53 PM
Hemispherx BioPharma (Issuer)
RODINO III PETER W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
1:58 PM
Hemispherx BioPharma (Issuer)
STRAYER DAVID R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
12:23 PM
EQUELS THOMAS K. (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
10:57 AM
Hemispherx BioPharma (Issuer)
PASCALE ADAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
1:42 PM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
1:06 PM
APPELROUTH STEWART (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
11:04 AM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
3:06 PM
Hemispherx BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
4:28 PM
Hemispherx BioPharma (Filer)
Form 424B3
05/02/2019
4:27 PM
Hemispherx BioPharma (Filer)
Form 424B3
05/02/2019
7:56 AM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2019
12:51 PM
EQUELS THOMAS K. (Filed by)
Hemispherx BioPharma (Subject)
Form SC 13D
04/05/2019
3:31 PM
Hemispherx BioPharma (Filer)
Form PRE 14A
04/05/2019
11:08 AM
Hemispherx BioPharma (Subject)
Iliad Research & Trading, L.P. (Filed by)
Form SC 13G
03/13/2019
1:55 PM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
1:34 PM
APPELROUTH STEWART (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
12:19 PM
Hemispherx BioPharma (Issuer)
SPRINGATE WAYNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
11:51 AM
Hemispherx BioPharma (Issuer)
STRAYER DAVID R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
10:27 AM
Hemispherx BioPharma (Issuer)
RODINO III PETER W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
3:29 PM
EQUELS THOMAS K. (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
12:40 PM
Hemispherx BioPharma (Issuer)
PASCALE ADAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
2:14 PM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2019
7:56 AM
Hemispherx BioPharma (Filer)
Form 424B5
02/27/2019
7:55 AM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2019
4:30 PM
Hemispherx BioPharma (Filer)
Form 424B3
02/14/2019
11:15 PM
Hemispherx BioPharma (Filer)
Form EFFECT
02/11/2019
9:09 AM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2019
4:04 PM
Hemispherx BioPharma (Filer)
Form S-1/A
01/30/2019
11:35 AM
APPELROUTH STEWART (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
11:12 AM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
10:36 AM
Hemispherx BioPharma (Issuer)
STRAYER DAVID R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
10:24 AM
Hemispherx BioPharma (Issuer)
RODINO III PETER W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
9:59 AM
Hemispherx BioPharma (Issuer)
PASCALE ADAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
9:46 AM
Hemispherx BioPharma (Issuer)
SPRINGATE WAYNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
9:20 AM
EQUELS THOMAS K. (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
1:22 PM
Hemispherx BioPharma (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
12/27/2018
4:24 PM
Hemispherx BioPharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/11/2018
3:14 PM
Hemispherx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2018
10:32 AM
EQUELS THOMAS K. (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
11:16 AM
Hemispherx BioPharma (Issuer)
MITCHELL WILLIAM M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
10:27 AM
APPELROUTH STEWART (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
10:05 AM
Hemispherx BioPharma (Issuer)
RODINO III PETER W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
9:34 AM
EQUELS THOMAS K. (Reporting)
Hemispherx BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
9:11 AM
Hemispherx BioPharma (Issuer)
STRAYER DAVID R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
8:42 AM
Hemispherx BioPharma (Issuer)
SPRINGATE WAYNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
8:20 AM
Hemispherx BioPharma (Issuer)
PASCALE ADAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
11:16 AM
Hemispherx BioPharma (Issuer)
RODINO III PETER W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
10:55 AM
Hemispherx BioPharma (Issuer)
STRAYER DAVID R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
10:38 AM
Hemispherx BioPharma (Issuer)
SPRINGATE WAYNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Featured Article: What causes a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel